ATE221886T1 - Heterocyclyl-substituierte annellierte pyridine und pyrimidine als antagonisten des corticotropin freisetzenden hormons (crh), verwendbar für die behandlung von cns und stress - Google Patents
Heterocyclyl-substituierte annellierte pyridine und pyrimidine als antagonisten des corticotropin freisetzenden hormons (crh), verwendbar für die behandlung von cns und stressInfo
- Publication number
- ATE221886T1 ATE221886T1 AT98942330T AT98942330T ATE221886T1 AT E221886 T1 ATE221886 T1 AT E221886T1 AT 98942330 T AT98942330 T AT 98942330T AT 98942330 T AT98942330 T AT 98942330T AT E221886 T1 ATE221886 T1 AT E221886T1
- Authority
- AT
- Austria
- Prior art keywords
- antagonists
- stress
- treatment
- corticotropin releasing
- crh
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5743297P | 1997-09-02 | 1997-09-02 | |
PCT/US1998/018080 WO1999011643A1 (en) | 1997-09-02 | 1998-09-01 | Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE221886T1 true ATE221886T1 (de) | 2002-08-15 |
Family
ID=22010535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98942330T ATE221886T1 (de) | 1997-09-02 | 1998-09-01 | Heterocyclyl-substituierte annellierte pyridine und pyrimidine als antagonisten des corticotropin freisetzenden hormons (crh), verwendbar für die behandlung von cns und stress |
Country Status (11)
Country | Link |
---|---|
US (2) | US6245769B1 (de) |
EP (1) | EP1012151B1 (de) |
JP (1) | JP2001514260A (de) |
CN (1) | CN1278819A (de) |
AT (1) | ATE221886T1 (de) |
AU (1) | AU9041198A (de) |
BR (1) | BR9814458A (de) |
CA (1) | CA2303280A1 (de) |
DE (1) | DE69807085D1 (de) |
IL (1) | IL134748A0 (de) |
WO (1) | WO1999011643A1 (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6992188B1 (en) | 1995-12-08 | 2006-01-31 | Pfizer, Inc. | Substituted heterocyclic derivatives |
CA2387703A1 (en) | 1999-10-01 | 2001-04-12 | Johnson & Johnson Consumer Companies, Inc. | Method for calming human beings using personal care compositions |
HUP0301801A2 (hu) * | 2000-07-14 | 2003-09-29 | Bristol-Myers Squibb Pharma Company | Imidazo[1,2-a]pirazin-származékok és az ezeket tartalmazó gyógyszerkészítmények |
US20020151527A1 (en) * | 2000-12-20 | 2002-10-17 | Benjamin Wiegand | Method for reducing acne or improving skin tone |
US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
CZ20032481A3 (cs) | 2001-03-13 | 2007-12-27 | Bristol-Myers Squibb Pharma Company | 4-(2-Butylamino)-2, 7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo[1,5-A]-1, 3, 5-triazin, jeho enantiomery a farmaceuticky prijatelné soli jakoligandy receptoru faktoru uvolnujícího kortikotropin |
SK13752003A3 (en) * | 2001-05-14 | 2004-11-03 | Bristol Myers Squibb Pharma Co | Substituted pyrazinones, pyridines and pyrimidines as ligands of factor releasing corticotropine |
ES2307750T3 (es) | 2001-06-12 | 2008-12-01 | Glaxo Group Limited | Antagonistas del factor de liberacion de corticotropina. |
JP2004537537A (ja) | 2001-06-29 | 2004-12-16 | アブ サイエンス | 炎症性疾患を治療するためのチロシンキナーゼ阻害剤の使用法 |
WO2003002105A2 (en) * | 2001-06-29 | 2003-01-09 | Ab Science | Use of tyrosine kinase inhibitors for treating bone loss |
JP2005500041A (ja) | 2001-06-29 | 2005-01-06 | アブ サイエンス | 強力で選択的かつ非毒性のc−kit阻害剤 |
ATE343415T1 (de) | 2001-06-29 | 2006-11-15 | Ab Science | Die verwendung von c-kit hemmer zur behandlung von entzündlichen darmerkrankungen |
DK1401413T3 (da) | 2001-06-29 | 2007-03-26 | Ab Science | Anvendelse af tyrosinkinaseinhibitorer til behandling af allergiske sygdomme |
WO2003005969A2 (en) | 2001-07-12 | 2003-01-23 | Bristol-Myers Squibb Pharma Company | Tetrahydropurinones as corticotropin releasing factor |
WO2003006015A1 (en) | 2001-07-13 | 2003-01-23 | Bristol-Myers Squibb Pharma Company | Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands |
DK1433480T3 (da) * | 2001-07-13 | 2011-04-11 | Btg Internat Ltd Company | Lægemiddel indeholdende pyrimidin-derivat |
US20030119831A1 (en) | 2001-11-20 | 2003-06-26 | Hartz Richard A. | 3,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligands |
GB2411478A (en) * | 2002-01-29 | 2005-08-31 | Johnson & Johnson Consumer | Method of measuring the stress or relaxation level of a mammal |
GB0203045D0 (en) * | 2002-02-08 | 2002-03-27 | Johnson & Johnson Consumer | Method of afefecting sleep and sleep-related behaviours |
US20040175438A1 (en) * | 2003-03-03 | 2004-09-09 | Benjamin Wiegand | Methods for alleviating symptoms associated with menopause using sensory regimen |
CA2537916A1 (en) * | 2003-09-03 | 2005-03-31 | Neurogen Corporation | 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds |
US7572805B2 (en) | 2004-07-14 | 2009-08-11 | Bristol-Myers Squibb Company | Pyrrolo(oxo)isoquinolines as 5HT ligands |
WO2006073610A2 (en) * | 2004-11-23 | 2006-07-13 | Reddy Us Therapeutics, Inc. | Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
US7238702B2 (en) * | 2005-02-10 | 2007-07-03 | Bristol-Myers Squibb Company | Dihydroquinazolinones as 5HT modulators |
CA2609659C (en) | 2005-05-26 | 2014-01-28 | Neuron Systems, Inc. | Azanaphthalenes, compositions and methods for treating retinal disease |
CN101268075A (zh) * | 2005-07-28 | 2008-09-17 | 百时美施贵宝公司 | 作为5-羟色胺受体激动剂和拮抗剂的取代的四氢-1h吡啶并[4,3,b]吲哚 |
US7795436B2 (en) * | 2005-08-24 | 2010-09-14 | Bristol-Myers Squibb Company | Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists |
US7851468B2 (en) * | 2006-05-15 | 2010-12-14 | Cephalon, Inc. | Substituted pyrazolo[3,4-d]pyrimidines |
TW200815349A (en) | 2006-06-22 | 2008-04-01 | Astrazeneca Ab | New compounds |
TW200902499A (en) | 2007-05-15 | 2009-01-16 | Astrazeneca Ab | New compounds |
ES2494365T3 (es) * | 2008-01-30 | 2014-09-15 | Genentech, Inc. | Compuestos de pirazolopirimidina que inhiben PI3K y métodos de uso |
TW201020244A (en) | 2008-11-14 | 2010-06-01 | Astrazeneca Ab | New compounds |
US8653098B2 (en) | 2008-11-20 | 2014-02-18 | Genentech, Inc. | Pyrazolopyridine PI3K inhibitor compounds and methods of use |
US20120220581A1 (en) | 2009-10-30 | 2012-08-30 | Janssen-Cilag, S.A. | IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
WO2011082267A2 (en) | 2009-12-30 | 2011-07-07 | Arqule, Inc. | Substituted triazolo-pyrazine compounds |
AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
WO2013000924A1 (en) | 2011-06-27 | 2013-01-03 | Janssen Pharmaceutica Nv | 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES |
CA2872216C (en) | 2012-06-26 | 2021-07-20 | Janssen Pharmaceutica Nv | Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl-[1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders |
JP6174695B2 (ja) | 2012-07-09 | 2017-08-02 | ヤンセン ファーマシューティカ エヌ.ベー. | ホスホジエステラーゼ10酵素の阻害剤 |
PE20191528A1 (es) | 2013-09-06 | 2019-10-23 | Hoffmann La Roche | Nuevos derivados de triazolo[4,5-d]pirimidina |
CN107709326B (zh) | 2015-02-18 | 2021-12-17 | 巴克老龄问题研究所 | 降低应激诱导的p-tau的三唑并吡啶和三唑并嘧啶 |
CA2996183A1 (en) | 2015-08-21 | 2017-03-02 | Aldeyra Therapeutics, Inc. | Deuterated compounds and uses thereof |
WO2019075136A1 (en) * | 2017-10-10 | 2019-04-18 | Aldeyra Therapeutics, Inc. | TREATMENT OF INFLAMMATORY DISORDERS |
WO2019154294A1 (zh) * | 2018-02-06 | 2019-08-15 | 江苏恒瑞医药股份有限公司 | 吡唑并[1,5-a][1,3,5]三嗪-2-胺类衍生物、其制备方法及其在医药上的应用 |
WO2020033344A1 (en) | 2018-08-06 | 2020-02-13 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
CN113056353B (zh) | 2018-09-25 | 2022-11-01 | 奥尔德拉医疗公司 | 用于治疗干眼病的调配物 |
WO2020198064A1 (en) | 2019-03-26 | 2020-10-01 | Aldeyra Therapeutics, Inc. | Ophthalmic formulations and uses thereof |
CN112479956A (zh) * | 2019-07-30 | 2021-03-12 | 杭州阿诺生物医药科技有限公司 | 一种用于制备腺苷受体抑制剂中间体的方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2643903A1 (fr) | 1989-03-03 | 1990-09-07 | Union Pharma Scient Appl | Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux |
ATE139232T1 (de) * | 1989-10-11 | 1996-06-15 | Teijin Ltd | Bizyklische pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung |
IT227968Y1 (it) | 1992-11-17 | 1998-01-21 | Moris Baroni | Ago per endovene e prelievi di forma estensibile, autoinglobante per evitare punture e contagi a persone e ambienti dopo l'uso |
TW444018B (en) * | 1992-12-17 | 2001-07-01 | Pfizer | Pyrazolopyrimidines |
WO1995010506A1 (en) * | 1993-10-12 | 1995-04-20 | The Du Pont Merck Pharmaceutical Company | 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
AU2265495A (en) | 1994-06-06 | 1996-01-04 | Pfizer Inc. | Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity |
TW574214B (en) * | 1994-06-08 | 2004-02-01 | Pfizer | Corticotropin releasing factor antagonists |
DK0765327T3 (da) * | 1994-06-16 | 1999-11-29 | Pfizer | Pyrazolo- og pyrrolopyridiner |
US5563143A (en) | 1994-09-21 | 1996-10-08 | Pfizer Inc. | Catechol diether compounds as inhibitors of TNF release |
ES2203642T3 (es) * | 1995-06-07 | 2004-04-16 | Pfizer Inc. | Derivados de pirimidina heterociclicos con anillos condensados. |
PT778277E (pt) * | 1995-12-08 | 2003-11-28 | Pfizer | Derivados heterociclicos substituidos como antagonistas do crf |
PT888349E (pt) | 1996-01-23 | 2002-10-31 | Novartis Ag | Pirrolopirimidinas e processos para a sua preparacao |
TW440563B (en) * | 1996-05-23 | 2001-06-16 | Hoffmann La Roche | Aryl pyrimidine derivatives and a pharmaceutical composition thereof |
-
1998
- 1998-09-01 AU AU90411/98A patent/AU9041198A/en not_active Abandoned
- 1998-09-01 BR BR9814458-8A patent/BR9814458A/pt not_active IP Right Cessation
- 1998-09-01 US US09/145,231 patent/US6245769B1/en not_active Expired - Lifetime
- 1998-09-01 CN CN98810908A patent/CN1278819A/zh active Pending
- 1998-09-01 IL IL13474898A patent/IL134748A0/xx unknown
- 1998-09-01 JP JP2000508682A patent/JP2001514260A/ja active Pending
- 1998-09-01 WO PCT/US1998/018080 patent/WO1999011643A1/en active IP Right Grant
- 1998-09-01 CA CA002303280A patent/CA2303280A1/en not_active Abandoned
- 1998-09-01 EP EP98942330A patent/EP1012151B1/de not_active Expired - Lifetime
- 1998-09-01 AT AT98942330T patent/ATE221886T1/de not_active IP Right Cessation
- 1998-09-01 DE DE69807085T patent/DE69807085D1/de not_active Expired - Lifetime
-
2001
- 2001-02-21 US US09/789,673 patent/US6525056B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6525056B2 (en) | 2003-02-25 |
EP1012151A1 (de) | 2000-06-28 |
IL134748A0 (en) | 2001-04-30 |
EP1012151B1 (de) | 2002-08-07 |
CN1278819A (zh) | 2001-01-03 |
US20010025042A1 (en) | 2001-09-27 |
AU9041198A (en) | 1999-03-22 |
US6245769B1 (en) | 2001-06-12 |
DE69807085D1 (de) | 2002-09-12 |
JP2001514260A (ja) | 2001-09-11 |
CA2303280A1 (en) | 1999-03-11 |
WO1999011643A1 (en) | 1999-03-11 |
BR9814458A (pt) | 2001-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE221886T1 (de) | Heterocyclyl-substituierte annellierte pyridine und pyrimidine als antagonisten des corticotropin freisetzenden hormons (crh), verwendbar für die behandlung von cns und stress | |
MY132871A (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders | |
BG108425A (en) | Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor | |
DK0901374T3 (da) | Tetrahydropteridiner og pyridylpiperaziner til behandling af neurologiske forstyrrelser | |
IL137019A0 (en) | Azolo triazines and pyrimidines | |
ES2128544T3 (es) | Pirrolopirimidinas como antagonistas del crf. | |
LV12292A (lv) | Triazinu un pirimidinu azoloatvasinajumi | |
WO1997035539A3 (en) | Arylamino fused pyridines and pyrimidines | |
CO4230019A1 (es) | Antagonistas de neuroquinina diazabiciclica | |
MY146935A (en) | 4-(2-BUTYLAMINO-2, 7-DIMETHYL-8-(2-METHYL-6-METHOXYPYRID-3-yl) PYRAZOLO-[1,5-a]-1,3,5-TRIAZINE, ITS ENANTIOMERS AND PHARMACEUTICALLY ACCEPTABLE SALTS AS CORTICOTROPIN RELEASING FACTOR RECEPTOR LIGANDS | |
MY141976A (en) | Azolo triazines and pyrimidines | |
DE69210255T2 (de) | THIENOPYRAZIN-2,3-DIONE VERWENDBAR BEI DER BEHANDLUNG VON ZNS-STöRUNGEN, UND IHRE HERSTELLUNG. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |